The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution
Open accessAbstract
The ubiquitin-proteasome system (UPS) has been implicated in neurodegenerative diseases based on the presence of deposits consisting of ubiquitylated proteins in affected neurons. It has been postulated that aggregation-prone proteins associated with these disorders, such as α-synuclein, β-amyloid peptide, and polyglutamine proteins, compromise UPS function, and delay the degradation of other proteasome substrates. Many of these substrates play important regulatory roles in signaling, cell cycle progression, or apoptosis, and their inadvertent stabilization due to an overloaded and improperly functioning UPS may thus be responsible for cellular demise in neurodegeneration. Over the past decade, numerous studies have addressed the UPS dysfunction hypothesis using various model systems and techniques that differ in their readout and sensitivity. While an inhibitory effect of some disease proteins on the UPS has been demonstrated, increasing evidence attests that the UPS remains operative in many disease models, which opens new possibilities for treatment. In this review, we will discuss the paradigm shift that repositioned the UPS from being a prime suspect in the pathophysiology of neurodegeneration to an attractive therapeutic target that can be harnessed to accelerate the clearance of disease-linked proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“The UPS, which is the principal pathway for the clearance of short-lived, damaged, and misfolded proteins in the nucleus and cytoplasm, consists of two separate, consecutive steps: ubiquitylation and proteasomal degradation (Hershko and Ciechanover, 1998; Kleiger and Mayor, 2014).”
Backgroundα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679 · cited 4×
“However, ubiquitylation is involved in many cellular processes other than proteasomal degradation (Komander and Rape, 2012) and it is therefore difficult to extrapolate whether a possible build up in ubiquitylated proteins is a consequence of UPS impairment or reflects other changes in the ubiquitin homeostasis (Groot…”
BackgroundInfluentialLoss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500 · cited 1×
“For instance, a recent study reported the generation of an SCF-βTrCP ubiquitin ligase that selectively targets only activated ErbB receptor tyrosine kinases for degradation (Kong et al., 2014).”
BackgroundMechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. R. L., Wilson, E. M., Lubahn, D. B., Harding, A. E., & Fischbeck, K. H. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,784
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609 · cited 1×
“Both types of molecules combine a ubiquitin ligase interaction peptide with a small molecule ligand specific for the target protein (Sakamoto et al., 2001).”
BackgroundRavikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979 · cited 1×
“The most compelling evidence supporting a role of IBs as an adaptive response comes from live cell recordings, which show that IB formation correlates with increased survival in primary neurons expressing a mutant huntingtin fragment (Arrasate et al., 2004).”
BackgroundAggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,921
The pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900 · cited 1×
“…become apparent that Parkin Frontiers in Molecular Neuroscience www.frontiersin.org July 2014 | Volume 7 | Article 70 | 2 is also involved in the autophagy pathway that results in the degradation of dysfunctional mitochondria in lysosomes, a process known as mitophagy (Ashrafi and Schwarz, 2013).”
BackgroundDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“Parkin cooperates with the mitochondrial kinase PINK1, which has also been linked to PD, thus strengthening the genetic association between mitophagy and neurodegeneration (Clark et al., 2006; Park et al., 2006).”
BackgroundRecognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
Finley, D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081507.101607 · Cited by 1,764
Dynamics and diversity in autophagy mechanisms: lessons from yeast
Nakatogawa, H., Suzuki, K., Kamada, Y., & Ohsumi, Y. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2708 · Cited by 1,725
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“Parkin cooperates with the mitochondrial kinase PINK1, which has also been linked to PD, thus strengthening the genetic association between mitophagy and neurodegeneration (Clark et al., 2006; Park et al., 2006).”
BackgroundKawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A., & Yao, T.-P. (2003) · Cell · doi:10.1016/s0092-8674(03)00939-5 · Cited by 1,524
Watts, G. D. J., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., & Kimonis, V. E. (2004) · Nature Genetics · doi:10.1038/ng1332 · Cited by 1,391 · cited 2×
“Mutations in VCP cause multisystem proteinopathy (MSP), with among its spectrum of symptoms frontotemporal dementia (Watts et al., 2004), as well as the motor neuron disease amyotrophic lateral sclerosis (ALS) (Johnson et al., 2010).”
BackgroundTrinucleotide Repeat Disorders
Orr, H. T., & Zoghbi, H. Y. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113042 · Cited by 1,368
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291 · cited 2×
“REVIEW ARTICLE published: 31 July 2014 doi: 10.3389/fnmol.2014.00070”
BackgroundInfluentialExome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235 · cited 8×
“Keywords: neurodegeneration, ubiquitin, proteasome, proteolysis, protein quality control”
BackgroundInfluentialHDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., et al. (2007) · Nature · doi:10.1038/nature05853 · Cited by 1,234 · cited 10×
“Activation of the heat shock response may also contribute to lowering of AR half-life by geldanamycin analogs in SBMA models, as overexpression of heat shock proteins has been shown to also promote AR degradation (Bailey et al., 2002).”
BackgroundInfluentialReversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067
Cellular Defenses against Unfolded Proteins
Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 991
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Misfolded proteins partition between two distinct quality control compartments
Kaganovich, D., Kopito, R., & Frydman, J. (2008) · Nature · doi:10.1038/nature07195 · Cited by 932
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B.-H., Lee, M. J., Park, S., Oh, D.-C., Elsasser, S., Chen, P.-C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 893
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848 · cited 1×
“The development of quantitative mass spectrometry combined with efficient purification of ubiquitylated proteins or signature peptides from biological samples has been invaluable in undertaking detailed analysis of the ubiquitylated proteome in human diseases (Kessler, 2013).”
BackgroundGeneration of Destabilized Green Fluorescent Protein as a Transcription Reporter
Li, X., Zhao, X., Fang, Y., Jiang, X., Duong, T., Fan, C., Huang, C.-C., & Kain, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34970 · Cited by 846
Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease
Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
Meyer, H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 807
Carrell, R. W., & Lomas, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02073-4 · Cited by 807
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
Outeiro, T. F., & Lindquist, S. (2003) · Science · doi:10.1126/science.1090439 · Cited by 806
Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination
Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S.-I., Igarashi, K., Tamura, T., Tanaka, K., & Ichihara, A. (1992) · Nature · doi:10.1038/360597a0 · Cited by 783
The ubiquitin-proteasome system
Nandi, D., Tahiliani, P., Kumar, A., & Chandu, D. (2006) · Journal of Biosciences · doi:10.1007/bf02705243 · Cited by 758
Cummings, C. J., Mancini, M. A., Antalffy, B., DeFranco, D. B., Orr, H. T., & Zoghbi, H. Y. (1998) · Nature Genetics · doi:10.1038/502 · Cited by 744
Eukaryotic Stress Granules Are Cleared by Autophagy and Cdc48/VCP Function
Buchan, J. R., Kolaitis, R.-M., Taylor, J. P., & Parker, R. (2013) · Cell · doi:10.1016/j.cell.2013.05.037 · Cited by 737 · cited 1×
“…Hoppe, 2012; Meyer et al., 2012) and include ubiquitin-selective autophagy (Ju et al., 2009; Tresse et al., 2010), the clearance of stress granules (Buchan et al., 2013), mitochondrial integrity (Bartolome et al., 2013), Parkindependent mitophagy (Kim et al., 2013), and the DNA damage response…”
BackgroundReading protein modifications with interaction domains
Seet, B. T., Dikic, I., Zhou, M.-M., & Pawson, T. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1960 · Cited by 661
Proteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Selective autophagy: ubiquitin-mediated recognition and beyond
Kraft, C., Peter, M., & Hofmann, K. (2010) · Nature Cell Biology · doi:10.1038/ncb0910-836 · Cited by 639
Schneekloth, A. R., Pucheault, M., Tae, H. S., & Crews, C. M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.114 · Cited by 635
Waelter, S., Boeddrich, A., Lurz, R., Scherzinger, E., Lueder, G., Lehrach, H., & Wanker, E. E. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1393 · Cited by 631
Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
Korolchuk, V. I., Mansilla, A., Menzies, F. M., & Rubinsztein, D. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.021 · Cited by 610
Characterization and Dynamics of Aggresome Formation by a Cytosolic Gfp-Chimera✪
García-Mata, R., Bebök, Z., Sorscher, E. J., & Sztul, E. S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1239 · Cited by 595
Dragatsis, I., Levine, M. S., & Zeitlin, S. (2000) · Nature Genetics · doi:10.1038/81593 · Cited by 576
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M., & Masucci, M. G. (2000) · Nature Biotechnology · doi:10.1038/75406 · Cited by 553
Self-citationUbiquitin signals autophagic degradation of cytosolic proteins and peroxisomes
Kim, P. K., Hailey, D. W., Mullen, R. T., & Lippincott-Schwartz, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810611105 · Cited by 532
Radhakrishnan, S. K., Lee, C. S., Young, P., Beskow, A., Chan, J. Y., & Deshaies, R. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.029 · Cited by 526
Fluorescent fusion protein knockout mediated by anti-GFP nanobody
Caussinus, E., Kanca, O., & Affolter, M. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2180 · Cited by 510
Bennett, E. J., Bence, N. F., Jayakumar, R., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 509
Cummings, C. J., Reinstein, E., Sun, Y., Antalffy, B., Jiang, Y.-H., Ciechanover, A., Orr, H. T., Beaudet, A. L., & Zoghbi, H. Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81035-1 · Cited by 501
Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway
Kwak, M.-K., Wakabayashi, N., Greenlaw, J. L., Yamamoto, M., & Kensler, T. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8786-8794.2003 · Cited by 500
Global changes to the ubiquitin system in Huntington's disease
Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K.-Y., Zaitseva, T. S., Becker, C. H., Bates, G. P., Schulman, H., & Kopito, R. R. (2007) · Nature · doi:10.1038/nature06022 · Cited by 497 · cited 2×
“…has been particularly puzzling since the evidence for a globally dysfunctional UPS in cultured cells has largely been based on ectopic expression of the very same huntingtin fragment that is expressed in these mice (Bence et al., 2001; Jana et al., 2001; Bennett et al., 2007; Wang et al., 2008).”
BackgroundMethodTanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
Ju, J.-S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., & Weihl, C. C. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908115 · Cited by 494
Repeat expansion disease: progress and puzzles in disease pathogenesis
La Spada, A. R., & Taylor, J. P. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2748 · Cited by 488
Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease
Keck, S., Nitsch, R., Grune, T., & Ullrich, O. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01642.x · Cited by 483
(2001) · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 476
Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome
Lam, Y. A., Xu, W., DeMartino, G. N., & Cohen, R. E. (1997) · Nature · doi:10.1038/385737a0 · Cited by 455
Jana, N. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1049 · Cited by 452
Tan, J. M. M., Wong, E. S. P., Kirkpatrick, D. S., Pletnikova, O., Ko, H. S., Tay, S.-P., Ho, M. W. L., Troncoso, J., Gygi, S. P., Lee, M. K., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm320 · Cited by 445
Sittler, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1307 · Cited by 442
Tresse, E., Salomons, F. A., Vesa, J., Bott, L. C., Kimonis, V., Yao, T.-P., Dantuma, N. P., & Taylor, J. P. (2010) · Autophagy · doi:10.4161/auto.6.2.11014 · Cited by 437
Self-citationVenkatraman, P., Wetzel, R., Tanaka, M., Nukina, N., & Goldberg, A. L. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00151-0 · Cited by 424
Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., & Wolozin, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420
Degradation of α-Synuclein by Proteasome
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417
RPN-6 determines C. elegans longevity under proteotoxic stress conditions
Vilchez, D., Morantte, I., Liu, Z., Douglas, P. M., Merkwirth, C., Rodrigues, A. P. C., Manning, G., & Dillin, A. (2012) · Nature · doi:10.1038/nature11315 · Cited by 413
Perilous journey: a tour of the ubiquitin–proteasome system
Kleiger, G., & Mayor, T. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.12.003 · Cited by 409
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Tanaka, F., Inukai, A., Doyu, M., & Sobue, G. (2005) · Nature Medicine · doi:10.1038/nm1298 · Cited by 395
Increased proteasome activity in human embryonic stem cells is regulated by PSMD11
Vilchez, D., Boyer, L., Morantte, I., Lutz, M., Merkwirth, C., Joyce, D., Spencer, B., Page, L., Masliah, E., Berggren, W. T., et al. (2012) · Nature · doi:10.1038/nature11468 · Cited by 388
Aβ inhibits the proteasome and enhances amyloid and tau accumulation
Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., & LaFerla, F. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.014 · Cited by 384
Burnett, B. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg344 · Cited by 373
Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila
Yang, Y., Nishimura, I., Imai, Y., Takahashi, R., & Lu, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00143-0 · Cited by 364
Delivery of ubiquitinated substrates to protein-unfolding machines
Elsasser, S., & Finley, D. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-742 · Cited by 364
Monitoring Activity and Inhibition of 26S Proteasomes with Fluorogenic Peptide Substrates
Kisselev, A. F., & Goldberg, A. L. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)98030-0 · Cited by 346
Olzmann, J. A., Li, L., Chudaev, M. V., Chen, J., Perez, F. A., Palmiter, R. D., & Chin, L.-S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611128 · Cited by 339
Crippa, V., Sau, D., Rusmini, P., Boncoraglio, A., Onesto, E., Bolzoni, E., Galbiati, M., Fontana, E., Marino, M., Carra, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq257 · Cited by 330 · cited 2×
“…Yeast GFPu Yes Outeiro and Lindquist, 2003 LRRK2 HeLa cell line UbG76V-GFP Yes Lichtenberg et al., 2011 ALS SOD1 NSC34 cell line YFPu Yes Crippa et al., 2010; Onesto et al., 2011 NES/NLS-YFPu No Sau et al., 2007 C2C12 cell line YFPu No Onesto et al., 2011 SOD1G93A mice UbG76V-GFP…”
BackgroundAlmeida, C. G., Takahashi, R. H., & Gouras, G. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5078-05.2006 · Cited by 316 · cited 1×
“…neurons Yes Lopez Salon et al., 2003 Neuro2a and N9 cell lines; primary astrocytes and microglia No Orre et al., 2013 Tg2576 mice Yes Oh et al., 2005; Almeida et al., 2006 3xTg-AD mice Yes/Nob Tseng et al., 2008 APP/PS1 mice Yes/Noc Aso et al., 2012 No Orre et al., 2013 AD postmortem brain Yes…”
BackgroundIlling, M. E., Rajan, R. S., Bence, N. F., & Kopito, R. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204955200 · Cited by 313
Reits, E., Griekspoor, A., Neijssen, J., Groothuis, T., Jalink, K., van Veelen, P., Janssen, H., Calafat, J., Drijfhout, J. W., & Neefjes, J. (2003) · Immunity · doi:10.1016/s1074-7613(02)00511-3 · Cited by 299
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity
Duennwald, M. L., & Lindquist, S. (2008) · Genes & Development · doi:10.1101/gad.1673408 · Cited by 299
Polyglutamine protein aggregates are dynamic
Kim, S., Nollen, E. A. A., Kitagawa, K., Bindokas, V. P., & Morimoto, R. I. (2002) · Nature Cell Biology · doi:10.1038/ncb863 · Cited by 298
Rubin, D. M., Glickman, M. H., Larsen, C. N., Dhruvakumar, S., & Finley, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.4909 · Cited by 297
Aggregate formation inhibits proteasomal degradation of polyglutamine proteins
Verhoef, L. G. G. C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2689 · Cited by 292
Inefficient degradation of truncated polyglutamine proteins by the proteasome
Holmberg, C. I., Staniszewski, K. E., Mensah, K. N., Matouschek, A., & Morimoto, R. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600426 · Cited by 289
Tsai, Y. C., Fishman, P. S., Thakor, N. V., & Oyler, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212235200 · Cited by 283
Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J., & Davies, K. J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277145 · Cited by 282
The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks
Acs, K., Luijsterburg, M. S., Ackermann, L., Salomons, F. A., Hoppe, T., & Dantuma, N. P. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2188 · Cited by 276
Self-citationUrushitani, M., Kurisu, J., Tsukita, K., & Takahashi, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01211.x · Cited by 268
Warrick, J. M., Morabito, L. M., Bilen, J., Gordesky-Gold, B., Faust, L. Z., Paulson, H. L., & Bonini, N. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.030 · Cited by 267
The Androgen Receptor in Health and Disease
Matsumoto, T., Sakari, M., Okada, M., Yokoyama, A., Takahashi, S., Kouzmenko, A., & Kato, S. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183656 · Cited by 266
Winborn, B. J., Travis, S. M., Todi, S. V., Scaglione, K. M., Xu, P., Williams, A. J., Cohen, R. E., Peng, J., & Paulson, H. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803692200 · Cited by 263
Disease-Associated Prion Protein Oligomers Inhibit the 26S Proteasome
Kristiansen, M., Deriziotis, P., Dimcheff, D. E., Jackson, G. S., Ovaa, H., Naumann, H., Clarke, A. R., van Leeuwen, F. W. B., Menéndez-Benito, V., Dantuma, N. P., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.001 · Cited by 263
Self-citationRecovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice
Zu, T., Duvick, L. A., Kaytor, M. D., Berlinger, M. S., Zoghbi, H. Y., Clark, H. B., & Orr, H. T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2978-04.2004 · Cited by 262
Nuclear Inclusions in Glutamine Repeat Disorders
Sisodia, S. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81743-2 · Cited by 259
Bodner, R. A., Outeiro, T. F., Altmann, S., Maxwell, M. M., Cho, S. H., Hyman, B. T., McLean, P. J., Young, A. B., Housman, D. E., & Kazantsev, A. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511256103 · Cited by 256
The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks
Meerang, M., Ritz, D., Paliwal, S., Garajova, Z., Bosshard, M., Mailand, N., Janscak, P., Hübscher, U., Meyer, H., & Ramadan, K. (2011) · Nature Cell Biology · doi:10.1038/ncb2367 · Cited by 254
Why do cellular proteins linked to K63‐polyubiquitin chains not associate with proteasomes?
Nathan, J. A., Tae Kim, H., Ting, L., Gygi, S. P., & Goldberg, A. L. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.354 · Cited by 253
Neuronal Induction of the Immunoproteasome in Huntington's Disease
Díaz-Hernández, M., Hernández, F., Martín-Aparicio, E., Gómez-Ramos, P., Morán, M. A., Castaño, J. G., Ferrer, I., Avila, J., & Lucas, J. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11653.2003 · Cited by 252
Assembly, structure, and function of the 26S proteasome
Bedford, L., Paine, S., Sheppard, P. W., Mayer, R. J., & Roelofs, J. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.03.007 · Cited by 252
Polarised Asymmetric Inheritance of Accumulated Protein Damage in Higher Eukaryotes
Rujano, M. A., Bosveld, F., Salomons, F. A., Dijk, F., van Waarde, M. A. W. H., van der Want, J. J. L., de Vos, R. A. I., Brunt, E. R., Sibon, O. C. M., & Kampinga, H. H. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040417 · Cited by 246
Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein
Yedidia, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5383 · Cited by 245
Kim, N. C., Tresse, E., Kolaitis, R.-M., Molliex, A., Thomas, R. E., Alami, N. H., Wang, B., Joshi, A., Smith, R. B., Ritson, G. P., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.029 · Cited by 242
Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes
Helmlinger, D. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh139 · Cited by 242
Regulated protein turnover: snapshots of the proteasome in action
Bhattacharyya, S., Yu, H., Mim, C., & Matouschek, A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3741 · Cited by 240
Bailey, C. K. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.515 · Cited by 236
Familial amyotrophic lateral sclerosis
Hand, C. K., & Rouleau, G. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10001 · Cited by 235
A transgenic mouse model of the ubiquitin/proteasome system
Lindsten, K., Menéndez-Benito, V., Masucci, M. G., & Dantuma, N. P. (2003) · Nature Biotechnology · doi:10.1038/nbt851 · Cited by 234
Self-citationAmyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro
Gregori, L., Fuchs, C., Figueiredo-Pereira, M. E., Van Nostrand, W. E., & Goldgaber, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19702 · Cited by 233
Family-Based Association between Alzheimer's Disease and Variants in UBQLN1
Bertram, L., Hiltunen, M., Parkinson, M., Ingelsson, M., Lange, C., Ramasamy, K., Mullin, K., Menon, R., Sampson, A. J., Hsiao, M. Y., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042765 · Cited by 229
Cdc48: a power machine in protein degradation
Stolz, A., Hilt, W., Buchberger, A., & Wolf, D. H. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.001 · Cited by 227
Chondrogianni, N., Tzavelas, C., Pemberton, A. J., Nezis, I. P., Rivett, A. J., & Gonos, E. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413007200 · Cited by 224
Defective ubiquitination of cerebral proteins in Alzheimer's disease
L�pez Salon, M., Morelli, L., Casta�o, E. M., Soto, E. F., & Pasquini, J. M. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001015)62:2<302::aid-jnr15>3.0.co;2-l · Cited by 224
Endoplasmic reticulum stress compromises the ubiquitin–proteasome system
Menéndez-Benito, V., Verhoef, L. G. G. C., Masucci, M. G., & Dantuma, N. P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi312 · Cited by 222
Self-citationPalazzolo, I., Stack, C., Kong, L., Musaro, A., Adachi, H., Katsuno, M., Sobue, G., Taylor, J. P., Sumner, C. J., Fischbeck, K. H., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.019 · Cited by 214
The immunology of neurodegeneration
Czirr, E., & Wyss-Coray, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58656 · Cited by 213
Bowman, A. B., Yoo, S.-Y., Dantuma, N. P., & Zoghbi, H. Y. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi064 · Cited by 213
Self-citationMutation of SOD1 in ALS: a gain of a loss of function
Sau, D., De Biasi, S., Vitellaro-Zuccarello, L., Riso, P., Guarnieri, S., Porrini, M., Simeoni, S., Crippa, V., Onesto, E., Palazzolo, I., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm110 · Cited by 212
Non-canonical ubiquitin-based signals for proteasomal degradation
Kravtsova-Ivantsiv, Y., & Ciechanover, A. (2012) · Journal of Cell Science · doi:10.1242/jcs.093567 · Cited by 211
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains
Mishto, M., Bellavista, E., Santoro, A., Stolzing, A., Ligorio, C., Nacmias, B., Spazzafumo, L., Chiappelli, M., Licastro, F., Sorbi, S., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.004 · Cited by 209
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer
Rodriguez-Gonzalez, A., Cyrus, K., Salcius, M., Kim, K., Crews, C. M., Deshaies, R. J., & Sakamoto, K. M. (2008) · Oncogene · doi:10.1038/onc.2008.320 · Cited by 206
Heiser, V., Engemann, S., Bröcker, W., Dunkel, I., Boeddrich, A., Waelter, S., Nordhoff, E., Lurz, R., Schugardt, N., Rautenberg, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182426599 · Cited by 205
A Fluorescent Broad-Spectrum Proteasome Inhibitor for Labeling Proteasomes In Vitro and In Vivo
Verdoes, M., Florea, B. I., Menendez-Benito, V., Maynard, C. J., Witte, M. D., van der Linden, W. A., van den Nieuwendijk, A. M. C. H., Hofmann, T., Berkers, C. R., van Leeuwen, F. W. B., et al. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.013 · Cited by 200
Self-citationAtaxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates
Zhong, X., & Pittman, R. N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl164 · Cited by 200
Al-Ramahi, I., Lam, Y. C., Chen, H.-K., de Gouyon, B., Zhang, M., Pérez, A. M., Branco, J., de Haro, M., Patterson, C., Zoghbi, H. Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601603200 · Cited by 198
Proteasomes Activate Aggresome Disassembly and Clearance by Producing Unanchored Ubiquitin Chains
Hao, R., Nanduri, P., Rao, Y., Panichelli, R. S., Ito, A., Yoshida, M., & Yao, T.-P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.016 · Cited by 197
Weihl, C. C., Dalal, S., Pestronk, A., & Hanson, P. I. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi426 · Cited by 195
Generalized brain and skin proteasome inhibition in Huntington’s disease
Seo, H., Sonntag, K., & Isacson, O. (2004) · Annals of Neurology · doi:10.1002/ana.20207 · Cited by 188
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
Wang, A. M., Miyata, Y., Klinedinst, S., Peng, H.-M., Chua, J. P., Komiyama, T., Li, X., Morishima, Y., Merry, D. E., Pratt, W. B., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1140 · Cited by 186
Reactive glia show increased immunoproteasome activity in Alzheimer’s disease
Orre, M., Kamphuis, W., Dooves, S., Kooijman, L., Chan, E. T., Kirk, C. J., Dimayuga Smith, V., Koot, S., Mamber, C., Jansen, A. H., et al. (2013) · Brain · doi:10.1093/brain/awt083 · Cited by 180
Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3
Wang, Q., Li, L., & Ye, Y. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605100 · Cited by 179
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration
Tsvetkov, A. S., Arrasate, M., Barmada, S., Ando, D. M., Sharma, P., Shaby, B. A., & Finkbeiner, S. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1308 · Cited by 178
The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation
Burnett, B. G., & Pittman, R. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407252102 · Cited by 176
Adachi, H., Waza, M., Tokui, K., Katsuno, M., Minamiyama, M., Tanaka, F., Doyu, M., & Sobue, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1242-07.2007 · Cited by 174
Pathare, G. R., Nagy, I., Bohn, S., Unverdorben, P., Hubert, Á., Körner, R., Nickell, S., Lasker, K., Šali, A., Tamura, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117648108 · Cited by 172
Durcan, T. M., Kontogiannea, M., Thorarinsdottir, T., Fallon, L., Williams, A. J., Djarmati, A., Fantaneanu, T. A., Paulson, H. L., & Fon, E. A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq452 · Cited by 171
Indirect inhibition of 26S proteasome activity in a cellular model of Huntington’s disease
Hipp, M. S., Patel, C. N., Bersuker, K., Riley, B. E., Kaiser, S. E., Shaler, T. A., Brandeis, M., & Kopito, R. R. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201110093 · Cited by 169
Kristiansen, M., Messenger, M. J., Klöhn, P., Brandner, S., Wadsworth, J. D. F., Collinge, J., & Tabrizi, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506600200 · Cited by 169
Impaired ubiquitin–proteasome system activity in the synapses of Huntington's disease mice
Wang, J., Wang, C.-E., Orr, A., Tydlacka, S., Li, S.-H., & Li, X.-J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200709080 · Cited by 169
Buckley, D. L., & Crews, C. M. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307761 · Cited by 168
Essential Role of E2-25K/Hip-2 in Mediating Amyloid-β Neurotoxicity
Song, S., Kim, S.-Y., Hong, Y.-M., Jo, D.-G., Lee, J.-Y., Shim, S. M., Chung, C.-W., Seo, S. J., Yoo, Y. J., Koh, J.-Y., et al. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.005 · Cited by 166
Amyloid peptide attenuates the proteasome activity in neuronal cells
Oh, S., Hong, H. S., Hwang, E., Sim, H. J., Lee, W., Shin, S. J., & Mook-Jung, I. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.07.006 · Cited by 166
Harnessing the Ubiquitination Machinery to Target the Degradation of Specific Cellular Proteins
Zhou, P., Bogacki, R., McReynolds, L., & Howley, P. M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00074-5 · Cited by 164
Riley, B. E., Kaiser, S. E., Shaler, T. A., Ng, A. C. Y., Hara, T., Hipp, M. S., Lage, K., Xavier, R. J., Ryu, K.-Y., Taguchi, K., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201005012 · Cited by 161
Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity
Palazzolo, I., Burnett, B. G., Young, J. E., Brenne, P. L., Spada, A. R. L., Fischbeck, K. H., Howell, B. W., & Pennuto, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm109 · Cited by 161
Cheroni, C., Marino, M., Tortarolo, M., Veglianese, P., De Biasi, S., Fontana, E., Zuccarello, L. V., Maynard, C. J., Dantuma, N. P., & Bendotti, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn319 · Cited by 159
Self-citationRelationship between β-amyloid degradation and the 26S proteasome in neural cells
Lopez Salon, M., Pasquini, L., Besio Moreno, M., Pasquini, J. M., & Soto, E. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00060-2 · Cited by 158
Kwak, M.-K., Cho, J.-M., Huang, B., Shin, S., & Kensler, T. W. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.029 · Cited by 157
Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels
Bartolome, F., Wu, H.-C., Burchell, V. S., Preza, E., Wray, S., Mahoney, C. J., Fox, N. C., Calvo, A., Canosa, A., Moglia, C., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.028 · Cited by 156 · cited 2×
“…inhibit the UPS (Tresse et al., 2010), whereas some of the VCP-mediated events mentioned above were altered (Ju et al., 2009; Tresse et al., 2010; Bartolome et al., 2013; Fujita et al., 2013; Kim et al., 2013), suggesting that the pathology caused by mutant VCP likely involves essential…”
BackgroundThe unique functions of tissue-specific proteasomes
Kniepert, A., & Groettrup, M. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.10.004 · Cited by 152
Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells
Seo, H., Sonntag, K., Kim, W., Cattaneo, E. F., & Ole Isacson, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000238 · Cited by 146
Wójcik, C., Schroeter, D., Wilk, S., et al. (1996) · PubMed · Cited by 144
Proteasome inhibition and Parkinson's disease modeling
Bové, J., Zhou, C. H., Jackson-Lewis, V. R., Taylor, J. P., Chu, Y., Rideout, H. J., Wu, D.-C., Kordower, J. H., Petrucelli, L., & Przedborski, S. (2006) · Annals of Neurology · doi:10.1002/ana.20937 · Cited by 143
RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1
Park, J., Al‐Ramahi, I., Tan, Q., Mollema, N., Diaz-García, J. R., Gallego‐Flores, T., Lu, H., Lagalwar, S., Duvick, L. A., Kang, H., et al. (2013) · Nature · doi:10.1038/nature12204 · Cited by 142
Fluorescent probes for proteolysis: Tools for drug discovery
Neefjes, J., & Dantuma, N. P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1282 · Cited by 136
Self-citationMorishima, Y., Wang, A. M., Yu, Z., Pratt, W. B., Osawa, Y., & Lieberman, A. P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn296 · Cited by 136
Liu, Y., Hettinger, C. L., Zhang, D., Rezvani, K. S., Wang, X., & Wang, H. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12647 · Cited by 136
Okuhira, K., Demizu, Y., Hattori, T., Ohoka, N., Shibata, N., Nishimaki‐Mogami, T., Okuda, H., Kurihara, M., & Naito, M. (2013) · Cancer Science · doi:10.1111/cas.12272 · Cited by 133
Molecular chaperones throughout the life cycle of the androgen receptor
Prescott, J., & Coetzee, G. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.037 · Cited by 131
Díaz-Hernández, M., Valera, A. G., Morán, M. A., Gómez‐Ramos, P., Alvarez‐Castelao, B., Castaño, J. G., Hernández, F., & Lucas, J. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03968.x · Cited by 128
Lack of Proteasome Active Site Allostery as Revealed by Subunit-Specific Inhibitors
Myung, J., Kim, K. B., Lindsten, K., Dantuma, N. P., & Crews, C. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00188-5 · Cited by 128
Self-citationDeriziotis, P., André, R., Smith, D. M., Goold, R., Kinghorn, K. J., Kristiansen, M., Nathan, J. A., Rosenzweig, R., Krutauz, D., Glickman, M. H., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.224 · Cited by 126
Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components
Stenoien, D. L., Mielke, M., & Mancini, M. A. (2002) · Nature Cell Biology · doi:10.1038/ncb859 · Cited by 125
Tokui, K., Adachi, H., Waza, M., Katsuno, M., Minamiyama, M., Doi, H., Tanaka, K., Hamazaki, J., Murata, S., Tanaka, F., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn419 · Cited by 125
Polyglutamine Expansion, Protein Aggregation, Proteasome Activity, and Neural Survival
Ding, Q., Lewis, J. J., Strum, K. M., Dimayuga, E. R., Bruce‐Keller, A. J., Dunn, J. C., & Keller, J. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107706200 · Cited by 124
Mitra, S. S., Tsvetkov, A. S., & Finkbeiner, S. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806269200 · Cited by 121
Gitcho, M. A., Strider, J., Carter, D. R., Taylor‐Reinwald, L., Forman, M. S., Goate, A., & Cairns, N. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900992200 · Cited by 121
Lee, M. K., Hyun, D. H., Marshall, K. A., Ellerby, L. M., Bredesen, D. E., Jenner, P., & Halliwell, B. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00633-5 · Cited by 121
Bett, J. S., Goellner, G. M., Woodman, B., Pratt, G. W., Rechsteiner, M., & Bates, G. P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi423 · Cited by 119
Aso, E., Lomoio, S., López‐González, I., Joda, L., Carmona, M., Fernández‐Yagüe, N., Moreno, J., Juvés, S., Pujol, A., Pamplona, R., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00560.x · Cited by 118
Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin
Dantuma, N. P., & Hoppe, T. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.06.003 · Cited by 112
Self-citationProteasome overload is a common stress factor in multiple forms of inherited retinal degeneration
Lobanova, E. S., Finkelstein, S., Skiba, N. P., & Arshavsky, V. Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305521110 · Cited by 108
Proteasome dysfunction in aged human α-synuclein transgenic mice
Chen, L., Thiruchelvam, M. J., Madura, K., & Richfield, E. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.004 · Cited by 103
Mutant protein in Huntington disease is resistant to proteolysis in affected brain
Dyer, R. B., & McMurray, C. T. (2001) · Nature Genetics · doi:10.1038/ng745 · Cited by 101
Trollet, C., Anvar, S. Y., Venema, A., Hargreaves, I. P., Foster, K., Vignaud, A., Ferry, A., Négroni, E., Hourdé, C., Baraibar, M. A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq098 · Cited by 99
Ortega, Z., Díaz-Hernández, M., Maynard, C. J., Hernández, F., Dantuma, N. P., & Lucas, J. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5673-09.2010 · Cited by 98
Self-citationMaynard, C. J., Böttcher, C., Ortega, Z., Smith, R. A., Florea, B. I., Díaz-Hernández, M., Brundin, P., Overkleeft, H. S., Li, J., Lucas, J. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906463106 · Cited by 98
Self-citationAyadi, A. E., Stieren, E. S., Barral, J. M., & Boehning, D. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206786109 · Cited by 96
Juenemann, K., Schipper-Krom, S., Wiemhoefer, A., Kloß, A., Sanz, A. S., & Reits, E. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.486076 · Cited by 93
Bhutani, N., Venkatraman, P., & Goldberg, A. L. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601592 · Cited by 89
Degradation Signals Recognized by the Ubc6p-Ubc7p Ubiquitin-Conjugating Enzyme Pair
Gilon, T., Chomsky, O., & Kulka, R. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7214-7219.2000 · Cited by 88
Link, C. D., Fonte, V. G., Hiester, B. G., Yerg, J., Ferguson, J., Csontos, S., Silverman, M. A., & Stein, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505581200 · Cited by 85
Parkin Directly Modulates 26S Proteasome Activity
Um, J. W., Im, E., Lee, H. J., Min, B., Yoo, L., Yoo, J., Lübbert, H., Stichel-Gunkel, C. C., Cho, H.-S., Yoon, J. B., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2862-09.2010 · Cited by 83
Chondrogianni, N., & Gonos, E. S. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.01.012 · Cited by 79
Fujita, K., Nakamura, Y., Oka, T., Ito, H., Tamura, T., Tagawa, K., Sasabe, T., Katsuta, A., Motoki, K., Shiwaku, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2828 · Cited by 77
Onesto, E., Rusmini, P., Crippa, V., Ferri, N., Zito, A., Galbiati, M., & Poletti, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07298.x · Cited by 72
Viswanathan, J., Haapasalo, A., Böttcher, C., Miettinen, R. A., Kurkinen, K. M. A., Lu, A., Thomas, A., Maynard, C. J., Romano, D., Hyman, B. T., et al. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01149.x · Cited by 71
Self-citationRusmini, P., Sau, D., Crippa, V., Palazzolo, I., Simonini, F., Onesto, E., Martini, L., & Poletti, A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.015 · Cited by 70
Lee, F. K. M., Wong, A. K. Y., Lee, Y. W., Wan, O. W., Chan, H. Y. E., & Chung, K. K. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06124.x · Cited by 69
Malik, B. A., Nirmalananthan, N., Gray, A. L., Spada, A. R. L., Hanna, M. G., & Greensmith, L. (2013) · Brain · doi:10.1093/brain/aws343 · Cited by 69
Proteasome degrades soluble expanded polyglutamine completely and efficiently
Michalik, A., & Broeckhoven, C. V. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.020 · Cited by 68
Grimberg, K. B., Beskow, A., Lundin, D., Davis, M. M., & Young, P. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00799-10 · Cited by 68
Lichtenberg, M., Mansilla, A., Zecchini, V. R., Fleming, A., & Rubinsztein, D. C. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.81 · Cited by 66
Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies
Schipper-Krom, S., Juenemann, K., Jansen, A. H. P., Wiemhoefer, A., van den Nieuwendijk, R., Smith, D. L., Hink, M. A., Bates, G. P., Overkleeft, H. S., Ovaa, H., et al. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.023 · Cited by 65
Rinaldi, C., Bott, L. C., Chen, K., Harmison, G. G., Katsuno, M., Sobue, G., Pennuto, M., & Fischbeck, K. H. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00271 · Cited by 64
Self-citation
Cited by
The logic of the 26S proteasome.
Collins, G. A., & Goldberg, A. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.023 · Cited by 933
“Decreased 26S activity has often been suggested in models of neurodegenerative disease (Dantuma and Bott, 2014) and even cardiac disease (Ranek et al., 2013).”
Remaining mysteries of molecular biology: the role of polyamines in the cell
Miller-Fleming, L., Olin-Sandoval, V., Campbell, K., & Ralser, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.06.020 · Cited by 658
Protein misfolding in neurodegenerative diseases: Implications and strategies
Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., Nurmi, A., et al. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0077-5 · Cited by 675
“Defects in both the UPS and autophagy pathways of protein degradation are often seen in neurodegenerative diseases [79, 80].”
BackgroundParkinson’s disease: animal models and dopaminergic cell vulnerability
Blesa, J., & Przedborski, S. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00155 · Cited by 480
Elusive roles for reactive astrocytes in neurodegenerative diseases
Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453
Metadata
- Authors
- Dantuma, N. P., & Bott, L. C.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-07-31
- Volume
- 7
- Pages
- 70-70
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2114452685
- Cited by
- 338
- References
- 221
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.